The approval represents the first major technological advance in CT in nearly a decade.
Just in time to commemorate the 50th anniversary of the first computed tomography (CT) scan, the US FDA announced it has granted 510(k) clearance to Siemens for its new NAEOTOM Alpha CT device, the first to utilize photon-counting.
The emergence of photon-counting detectors represents the next significant enhancement to CT use, allowing for more detailed information about the patient to be obtained while creating images with less information that is deemed not useful for review and analysis.
“About 15 years ago, work on photon-counting and its clinical vision started at Siemens Healthineers. We always believed in the tremendous clinical value and relentlessly worked on it together with our partners. We are excited that we have received FDA 510(k) clearance,” says André Hartung, Head of Diagnostic Imaging at Siemens Healthineers, in a statement.
By measuring each individual x-ray that passes through a patient’s body, photon-counting detectors can produce detailed three-dimensional images that can ultimately aid in making a diagnosis or treatment-related decisions.
“Computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality; planning and guiding interventional or therapeutic procedures; and monitoring the effectiveness of certain therapies,” said Laurel Burk, Ph.D., assistant director of the Diagnostic X-ray Systems Team in the FDA’s Center for Devices and Radiological Health, in a statement. “Today’s action represents the first major new technology for computed tomography imaging in nearly a decade and underscores the FDA’s efforts to encourage innovation in areas of scientific and diagnostic progress.”
The technology ultimately processes x-rays differently; transforming the current two-step process in which X-rays are converted into visible light, which is then detected by a light sensor, into a single-step process in which X-ray photons are directly converted into digital electrical signals that are counted, ultimately producing an image with greater clarity and contrast.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.